Evidence map›Paper›PMID 24937132›Full record

ArticlePloS one2014

Structure analysis and conformational transitions of the cell penetrating peptide transportan 10 in the membrane-bound state.

Susanne Fanghänel, Parvesh Wadhwani, Erik Strandberg, Wouter P R Verdurmen, Jochen Bürck, Sebastian Ehni, Pavel K Mykhailiuk, Sergii Afonin, Dagmar Gerthsen, Igor V Komarov and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Mastoparan M extracted fromIranian journal of basic medical sciences · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Cancer cell surface induced peptide folding allows intracellular translocation of drug.Journal of controlled release : official journal of the Controlled Release Society · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Susanne FanghänelKarlsruhe Institute of Technology (KIT), Institute of Organic Chemistry and DFG-Center for Functional Nanostructures (CFN), Karlsruhe, Germany.
Parvesh WadhwaniKIT, Institute of Biological Interfaces (IBG2), Karlsruhe, Germany.
Erik StrandbergKIT, Institute of Biological Interfaces (IBG2), Karlsruhe, Germany.
Wouter P R VerdurmenDepartment of Biochemistry, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.
Jochen BürckKIT, Institute of Biological Interfaces (IBG2), Karlsruhe, Germany.
Sebastian EhniKarlsruhe Institute of Technology (KIT), Institute of Organic Chemistry and DFG-Center for Functional Nanostructures (CFN), Karlsruhe, Germany.
Pavel K MykhailiukTaras Shevchenko National University of Kyiv, Chemistry Department, Kyiv, Ukraine and Enamine Ltd., Kyiv, Ukraine.
Sergii AfoninKIT, Institute of Biological Interfaces (IBG2), Karlsruhe, Germany.
Dagmar GerthsenKIT, Laboratory for Electron Microscopy, Karlsruhe, Germany.
Igor V KomarovTaras Shevchenko National University of Kyiv, Institute of High Technologies, Kyiv, Ukraine.
Roland BrockDepartment of Biochemistry, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.
Anne S UlrichKarlsruhe Institute of Technology (KIT), Institute of Organic Chemistry and DFG-Center for Functional Nanostructures (CFN), Karlsruhe, Germany; KIT, Institute of Biological Interfaces (IBG2), Karlsruhe, Germany.
Karlsruhe Institute of Technology · DERadboud University Medical Center · NLTaras Shevchenko National University of Kyiv · UA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Structure analysis of the cell-penetrating peptide transportan 10 (TP10) revealed an exemplary range of different conformations in the membrane-bound state. The bipartite peptide (derived N-terminally from galanin and C-terminally from mastoparan) was found to exhibit prominent characteristics of (i) amphiphilic α-helices, (ii) intrinsically disordered peptides, as well as (iii) β-pleated amyloid fibrils, and these conformational states become interconverted as a function of concentration. We used a complementary approach of solid-state (19)F-NMR and circular dichroism in oriented membrane samples to characterize the structural and dynamical behaviour of TP10 in its monomeric and aggregated forms. Nine different positions in the peptide were selectively substituted with either the L- or D-enantiomer of 3-(trifluoromethyl)-bicyclopent-[1.1.1]-1-ylglycine (CF3-Bpg) as a reporter group for (19)F-NMR. Using the L-epimeric analogs, a comprehensive three-dimensional structure analysis was carried out in lipid bilayers at low peptide concentration, where TP10 is monomeric. While the N-terminal region is flexible and intrinsically unstructured within the plane of the lipid bilayer, the C-terminal α-helix is embedded in the membrane with an oblique tilt angle of ∼ 55° and in accordance with its amphiphilic profile. Incorporation of the sterically obstructive D-CF3-Bpg reporter group into the helical region leads to a local unfolding of the membrane-bound peptide. At high concentration, these helix-destabilizing C-terminal substitutions promote aggregation into immobile β-sheets, which resemble amyloid fibrils. On the other hand, the obstructive D-CF3-Bpg substitutions can be accommodated in the flexible N-terminus of TP10 where they do not promote aggregation at high concentration. The cross-talk between the two regions of TP10 thus exerts a delicate balance on its conformational switch, as the presence of the α-helix counteracts the tendency of the unfolded N-terminus to self-assemble into β-pleated fibrils.

Indexed as

AmyloidCell MembraneCell-Penetrating PeptidesHeLa CellsHumansHydrogen BondingNuclear Magnetic Resonance, BiomolecularProtein BindingProtein Structure, QuaternaryProtein Structure, SecondaryRecombinant Fusion ProteinsAmyloidCell-Penetrating PeptidesRecombinant Fusion Proteinstransportan-10

Identifiers

PMID24937132
PMCPMC4061077
OpenAlexW1973510304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.